
Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome
Dravet SyndromeExpanded access to Stiripentol for patients with Dravet Syndrome.

Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma
Hepatocellular CarcinomaPatient with advanced liver cancer (cancer that has spread to other parts of the body) continues to receive the study drug (G-202) even though patient no longer meets the criteria to be a part of the main treatment study. Patient's cancer responded well to receiving G-202 in the main study and will receive G-202 at the same dose given in the main study.

Buphenyl Therapy for Byler's Disease
Byler DiseaseThis is a single patient compassionate use protocol to determine whether Buphenyl (4-phenylbutyrate) will improve the poor bile flow associated with Byler Disease.

Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing...
Pulmonary Arterial HypertensionIn an earlier study, sildenafil citrate administered to patients of PAH led to improvement in pulmonary arterial pressure, cardiac output, quality of life, and other parameters as compared to placebo. This protocol provides mechanism for patients who have clinical deterioration on other PAH approved therapies to have access to sildenafil prior to marketing authorization in India.

Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS...
Rheumatoid ArthritisAn expanded access trial of belimumab for named patients who participated in LBRA99.

Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil
Pulmonary Arterial HypertensionThe purpose of this study is to provide sildenafil therapy to patients who completed the A1481244 study for the treatment of PAH, and reside in Brazilian States where Revatio™ is not supplied by Health Secretary, and are judged by the Investigator to derive clinical benefit from continued treatment with Sildenafil. It will be supplied until patient gets access to Sildenafil through Brazilian State Health Secretary from where patient resides.

Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma
NeuroblastomaGE Healthcare has recently submitted a New Drug Application (NDA) for Iobenguane I 123 Injection ([123I]mIBG (AdreView)) as a diagnostic nuclear imaging agent for the detection of primary or metastatic neuroblastoma and pheochromocytoma. The present protocol establishes an Expanded Access program to provide AdreView to pediatric medical centers and hospitals that treat neuroblastoma patients. AdreView will be provided for use in diagnostic assessment of patients with known or suspected neuroblastoma for whom there is an appropriate clinical indication for [123I]mIBG imaging.

Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients
Lung TransplantCurrently there are no approved therapies for lung transplant recipients in the United States (US). Treatment with CIS following lung transplantation has previously been demonstrated to result in a clinically meaningful improvement in survival and chronic rejection-free survival compared to placebo, but additional data supporting its use is needed prior to Food and Drug Administration (FDA) approval. This treatment use protocol is a mechanism for providing eligible lung transplant recipients early access to CIS in advance of FDA approval.

This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor...
Non-Hodgkin's LymphomaHodgkin's Disease1 moreThe purpose of this program is to provide expanded access to plerixafor for patients with NHL, HD, or MM who are to receive treatment with an autologous peripheral stem cell transplant.

Pulmonary Vein Isolation Outcomes With Fish Oils
Atrial FibrillationFish oil therapy may decrease the incidence of cardiac arrhythmias. This study will test whether pre-treatment with fish oils before catheter ablation of atrial fibrillation decreases the early post operative occurrence of atrial fibrillation.